loader

asx:ivx

LATEST ARTICLES
Trading Halt
Biotech Investing

Trading Halt

Appendix 4E and Annual Report
Biotech Investing

Appendix 4E and Annual Report

Orphan Drug Designation Granted by U.S. FDA for Anal Cancer
Biotech Investing

Orphan Drug Designation Granted by U.S. FDA for Anal Cancer

Trading Halt
Biotech Investing

Trading Halt

Appendix 4C and Quarterly Activities Report - June 2025
Biotech Investing

Appendix 4C and Quarterly Activities Report - June 2025

Underwritten Loyalty Option Entitlement Offer Prospectus
Biotech Investing

Underwritten Loyalty Option Entitlement Offer Prospectus

Loyalty Option Entitlement Offer
Biotech Investing

Loyalty Option Entitlement Offer

Encouraging SRC Findings on Ph I/II Skin Cancer Trial
Biotech Investing

Encouraging SRC Findings on Ph I/II Skin Cancer Trial

Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial
biotech investing

Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial

Appendix 4C and Quarterly Activities Report - March 2025
biotech investing

Appendix 4C and Quarterly Activities Report - March 2025

Invion Limited (ASX:IVX)
pharmaceutical investing

Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases

Invion Limited
Pharmaceutical Investing

Invion Limited

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES